Contents

Search


liberation therapy

Credited to Paolo Zamboni, a vascular surgeon from the University of Ferrara in Italy Uses: - used to treat chronic cerebrospinal venous insufficiency (CCSVI) associated with symptoms of multiple sclerosis Contraindications: - not FDA-approved - no evidence of association of multiple sclerosis with CCSVI - no consensus on criteria for CCSVI - no evidence that the procedure effectively treats symptoms of multiple sclerosis [1] - ineffective for treatment of multiple sclerosis [3] - may exacerbate symptoms of multiple sclerosis in the short-term [3] Procedure: - angioplasty balloons are used to open narrowed veins in the neck and chest

General

venous angioplasy (percutaneous transluminal venous angioplasty)

References

  1. Physician's First Watch Massachusetts Medical Society, June 29, 2010
  2. FDA News Release: May 10, 2012 FDA issues alert on potential dangers of unproven treatment for multiple sclerosis. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm303538.htm
  3. Physician's First Watch. March 18, 2013 Fairchild DG, Editor-in-Chief Massachesetts Medical Society http://www.jwatch.org